Iron-binding characteristics of neuromelanin of the human substantia nigra
- PMID: 12907248
- DOI: 10.1016/s0006-2952(03)00293-4
Iron-binding characteristics of neuromelanin of the human substantia nigra
Abstract
The vulnerability of the dopaminergic neurons of the substantia nigra (SN) in Parkinson's disease has been related to the presence of the pigment neuromelanin (NM) in these neurons. It is hypothesised that NM may act as an endogenous storage molecule for iron, an interaction suggested to influence free radical production. The current study quantified and characterised the interaction between NM and iron. Iron-binding studies demonstrated that both NM and synthetically-produced dopamine melanin contain equivalent numbers of high and low-affinity binding sites for iron but that the affinity of NM for iron is higher than that of synthetic melanin. Quantification of the total iron content in iron-loaded NM and synthetic melanin demonstrated that the iron-binding capacity of NM is 10-fold greater than that of the model melanin. This data was in agreement with the larger iron cluster size demonstrated by Mössbauer spectroscopy in the native pigment compared with the synthetic melanin. These findings are consistent with the hypothesis that NM may act as an endogenous iron-binding molecule in dopaminergic neurons of the SN in the human brain. The interaction between NM and iron has implications for disorders such as Parkinson's disease where an increase in iron in the SN is associated with increased indices of oxidative stress.
Similar articles
-
Iron, melanin and dopamine interaction: relevance to Parkinson's disease.Prog Neuropsychopharmacol Biol Psychiatry. 1993 Jan;17(1):139-50. doi: 10.1016/0278-5846(93)90038-t. Prog Neuropsychopharmacol Biol Psychiatry. 1993. PMID: 8416600
-
Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction.J Neural Transm Suppl. 1990;29:251-8. doi: 10.1007/978-3-7091-9050-0_24. J Neural Transm Suppl. 1990. PMID: 2193109 Review.
-
Influence of neuromelanin on oxidative pathways within the human substantia nigra.Neurotoxicol Teratol. 2002 Sep-Oct;24(5):621-8. doi: 10.1016/s0892-0362(02)00218-0. Neurotoxicol Teratol. 2002. PMID: 12200193 Review.
-
The enigma of neuromelanin in Parkinson's disease substantia nigra.J Neural Transm Suppl. 1994;43:113-22. J Neural Transm Suppl. 1994. PMID: 7884393 Review.
-
The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.Brain. 2021 Nov 29;144(10):3114-3125. doi: 10.1093/brain/awab191. Brain. 2021. PMID: 33978742 Free PMC article.
Cited by
-
Neuromelanin enhances the toxicity of α-synuclein in SK-N-SH cells.J Neural Transm (Vienna). 2012 Jun;119(6):685-91. doi: 10.1007/s00702-011-0753-z. Epub 2011 Dec 27. J Neural Transm (Vienna). 2012. PMID: 22200858
-
Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?Front Neurol. 2019 Aug 8;10:833. doi: 10.3389/fneur.2019.00833. eCollection 2019. Front Neurol. 2019. PMID: 31440200 Free PMC article. Review.
-
Impaired Phasic Discharge of Locus Coeruleus Neurons Based on Persistent High Tonic Discharge-A New Hypothesis With Potential Implications for Neurodegenerative Diseases.Front Neurol. 2020 May 12;11:371. doi: 10.3389/fneur.2020.00371. eCollection 2020. Front Neurol. 2020. PMID: 32477246 Free PMC article.
-
Haem and non-haem iron intake through 17 years of adult life of a British Birth Cohort.Br J Nutr. 2007 Nov;98(5):1021-8. doi: 10.1017/S0007114507749255. Epub 2007 May 25. Br J Nutr. 2007. PMID: 17524184 Free PMC article.
-
Genetics of iron regulation and the possible role of iron in Parkinson's disease.Neurobiol Dis. 2008 Nov;32(2):183-95. doi: 10.1016/j.nbd.2008.07.001. Epub 2008 Jul 11. Neurobiol Dis. 2008. PMID: 18675357 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical